Fingerprint
Dive into the research topics of 'Docetaxel and Carboplatin as First-line Therapy in Advanced Non-small Cell Lung Carcinoma: A Phase II Study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Docetaxel and Carboplatin as First-line Therapy in Advanced Non-small Cell Lung Carcinoma: A Phase II Study
Mohammad Jahanzeb, Greg Sarna, Robert Hirsch, Peter Radice, Alan Koletsky, Manuel Martinez, Elena Kruglyak, Edward Wolin, Elber Camacho, Lori Kronish, Susannah Motl
Research output: Contribution to journal › Article › peer-review
10
Scopus
citations